Side-by-side comparison
LL-37 Truncated Variants (KR-12 / KS-30) vs IGF-1 DES
Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity. versus Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
IGF-1 DES
PerformanceTruncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.
Top benefits
- ✓Localized muscle hyperplasia
- ✓Stronger receptor binding than wild-type
| Attribute | LL-37 Truncated Variants (KR-12 / KS-30) | IGF-1 DES |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | protein |
| Chain length | 12 aa | 67 aa |
| Formula | KR-12 fragment of LL-37 | modified IGF-1 |
| Common dose | Not established | 20–50 mcg |
| Frequency | N/A | Post-workout |
| Top benefit | Antimicrobial activity preserved | Localized muscle hyperplasia |
| Top side-effect | Localized irritation (topical) | Hypoglycemia risk |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.